Erisyon
Developer commercializing a single-molecule, fluorescence-based protein sequencing platform. The company advances a sequencing workflow that labels selected amino acids, immobilizes peptides, performs repeated imaging and chemistry cycles to read fluorosequences, and matches those reads to reference databases. The technology is positioned for ultra-sensitive, high-throughput proteomics and applications including biomarker discovery, immuno-oncology, and infectious-disease glycoproteomics.
Industries
Nr. of Employees
small (1-50)
Products
Single-molecule protein sequencing platform
A laboratory platform that implements fluorescence-based single-molecule peptide sequencing (fluorosequencing) with massively parallel imaging and database-driven identification.
Technical white papers and application notes
Published white papers and application notes describing methodology, applications (e.g., single-cell proteomics, antigen discovery, Parkinson's biomarkers), and technical details of the sequencing approach.
Fluorosequencing
A massively parallel, single-molecule peptide sequencing technology developed by Erisyon, capable of quantifying healthy and pathological protein versions for early disease detection and other applications.
single-molecule protein sequencer
The world’s first single-molecule protein sequencer commercialized by Erisyon that promises to transform disease detection, treatment, and tracking.
Single-molecule protein sequencing platform
A laboratory platform that implements fluorescence-based single-molecule peptide sequencing (fluorosequencing) with massively parallel imaging and database-driven identification.
Technical white papers and application notes
Published white papers and application notes describing methodology, applications (e.g., single-cell proteomics, antigen discovery, Parkinson's biomarkers), and technical details of the sequencing approach.
Fluorosequencing
A massively parallel, single-molecule peptide sequencing technology developed by Erisyon, capable of quantifying healthy and pathological protein versions for early disease detection and other applications.
single-molecule protein sequencer
The world’s first single-molecule protein sequencer commercialized by Erisyon that promises to transform disease detection, treatment, and tracking.
Services
Collaborations and funded projects to develop and validate assays for early-detection biomarkers, neoantigen discovery, and viral glycosylation profiling.
Collaborations and funded projects to develop and validate assays for early-detection biomarkers, neoantigen discovery, and viral glycosylation profiling.
Expertise Areas
- Single-molecule proteomics
- Protein sequencing
- Post-translational modification mapping
- High-throughput single-molecule imaging
Key Technologies
- Single-molecule protein sequencing
- Fluorescence-based amino-acid labeling
- High-throughput single-molecule imaging
- Iterative chemistry (Edman-style) sequencing cycles
News & Updates
Press coverage describing the potential impact of a novel protein sequencing method.
Announcement of foundation grant to support development and validation of molecular biomarkers for earlier Parkinson's detection.
Authored and contributed to peer-reviewed articles (ACS Chemical Biology, Nature Biotechnology, PLOS Computational Biology, Royal Society of Chemistry) describing methods relevant to single-molecule proteomics.
Press coverage describing the potential impact of a novel protein sequencing method.
Announcement of foundation grant to support development and validation of molecular biomarkers for earlier Parkinson's detection.
Authored and contributed to peer-reviewed articles (ACS Chemical Biology, Nature Biotechnology, PLOS Computational Biology, Royal Society of Chemistry) describing methods relevant to single-molecule proteomics.